Tap any paragraph to write a margin note. Your notes collect in the Desk below the text and file under cases with @. The side-by-side margin rail opens on a larger screen.

Code · REGISTER · 2012-07-23 · DEPARTMENT OF HEALTH AND HUMAN SERVICES · Notices

Notices. DEPARTMENT OF HEALTH AND HUMAN SERVICES

398 words·~2 min read·/register/2012/07/23/2012-18026·

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

BILLING CODE 4165-15-P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Public Comment Period Extension for the Final Supplementary Risk Assessment for the Boston University
(BU)National Emerging Infectious Diseases Laboratories (NEIDL) SUMMARY: A Notice of Availability for the Final Supplementary Risk Assessment for the Boston University
(BU)National Emerging Infectious Diseases Laboratories (NEIDL) was published in the **Federal Register** on July 6, 2012. Upon the publication of the Notice of Availability, a required comment period of at least 30 day began in which the National Institutes of Health would accept and consider comments from the public on the final supplementary risk assessment. This comment period was set to end on August, 6, 2012. In order to provide the public with additional time to review and comment on the final supplementary risk assessment, the National Institutes of Health
(NIH)has decided to extend the public comment period for the final supplementary risk assessment until August 24, 2012. ADDRESSES: Written comments on the final supplementary risk assessment must be postmarked no later than August 24, 2012. Comments should be sent to The National Institutes of Health, Office of Biotechnology Activities, Attn: NEIDL Risk Assessment, 6705 Rockledge Drive, Suite 750, Bethesda, Maryland, 20892. Email comments should be sent to *NIH_BRP@od.nih.gov.* Please note that comments sent by email must be received by 11:59 p.m. on the last day of the comment period, August 24, 2012. FOR FURTHER INFORMATION CONTACT: National Institutes of Health Office of Biotechnology Activities, 6705 Rockledge Drive, Suite 750, Bethesda, Maryland, 20892. Telephone number:
(301)496-9838. Electronic mail address: *NIH_BRP@od.nih.gov.* *Availabilty of Copies and Electronic Access:* Copies of the Final Supplementary Risk Assessment for the Boston University National Emerging Infectious Diseases Laboratory and the accompanying reader's guide may be obtained at no cost by calling
(301)496-9838, or by emailing requests to *NIH_BRP@od.nih.gov* . The documents are also available electronically at: *http://nihblueribbonpanel-bumc-neidl.od.nih.gov/default.asp.* A copy of the final supplementary risk assessment and the reader's guide has also been made available for review at each of the following locations: Central Branch of the Boston Public Library, 700 Boylston Street, Boston, MA; South End Library, 685 Tremont Street, Boston, MA; Grove Hall Library, 42 Geneva Avenue; and Dudley Library, 65 Warren Street, Boston, MA. Dated: July 18, 2012. Ryan T. Bayha, Science Policy Analyst, Office of Science Policy, National Institutes of Health. [FR Doc. 2012-18026 Filed 7-20-12; 8:45 am]
★   the supreme law of the land   ★
Don't Tread on Me
E Pluribus Unum — out of many, one

"If you don't know your rights, you don't have any."

Marginalia · a citizen's law index
A research desk, not legal advice. Always read the cited source before relying on a summary.
Questions or an issue? support@self-law.org
disclaimerMarginalia is a research index, not a law firm. Nothing on this site is legal, tax, or financial advice and no attorney–client relationship is formed by using it. Statutes, regulations, and case law change; summaries, search results, AI output, and member posts may be incomplete, out of date, or wrong. Any interpretation drawn from material on this site should be validated by a licensed attorney in your jurisdiction before you act on it.